Healthcare Providers and Services
Company Overview of Pathway Genomics Corporation
Pathway Genomics Corporation operates a clinical laboratory to provide commercial genetic testing services to physicians and their patients in the United States and internationally. Its testing services cover various conditions, including cancer risk, cardiac health, inherited diseases, and nutrition and exercise response, as well as drug response for specific medications that are used in pain management and mental health. The company offers BRCATrue, BreastTrue high risk panel, ColoTrue, LynchSyndromeTrue, familial studies program, and genetic variant reclassification tests for cancer; pharmacogenomics related tests that comprise cardiac, mental health, medication, and pain medication DNA i...
4045 Sorrento Valley Boulevard
San Diego, CA 92121
Founded in 2008
Key Executives for Pathway Genomics Corporation
Founder, Chief Executive Officer and President
Vice President of Finance
President of Pathway Genomics International
Chief Technology Officer and Vice President of Engineering & Product Development
Compensation as of Fiscal Year 2015.
Pathway Genomics Corporation Key Developments
Pathway Genomics Appoints Paul Sonnier to Strategic Advisory Board
Jul 9 15
Pathway Genomics Corporation announced that Paul Sonnier, digital health advocate and social entrepreneur, is joining the company’s Strategic Advisory Board. Mr. Sonnier is globally recognized for his digital health advocacy, including promulgation of a modern definition of digital health that incorporates the impact of both the digital and genetics revolutions on health, healthcare, living, and society.
Pathway Genomics Corporation Appoints Peter Pace to Board of Directors
May 19 15
Pathway Genomics Corporation announced that the sixteenth chairman of the Joint Chiefs of Staff, retired U.S. Marine General Peter Pace is joining the company’s board of directors.
Pathway Genomics Corporation Appoints Jim Plante to Industry Trade Advisory Committee
May 14 15
Pathway Genomics Corporation announced that Founder and CEO Jim Plante has been appointed by the U.S. Secretary of Commerce, Penny Pritzker, and U.S. Trade Representative (USTR), Ambassador Michael Froman to the Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health and Science Products (ITAC 3). As a member of ITAC, Mr. Plante will provide the President, through the Commerce Secretary and the Office of the United States Trade Representative (USTR), with detailed policy and technical advice, information, and recommendations regarding trade barriers, negotiation of trade agreements, and implementation of existing trade agreements affecting industry sectors. His term expires February 2018.
Similar Private Companies By Industry
Recent Private Companies Transactions
November 12, 2014